Cytosorbents (CTSO) Non-Current Deferred Tax Liability (2018 - 2021)

Cytosorbents (CTSO) has reported Non-Current Deferred Tax Liability for 4 consecutive years, with $183941.0 the latest figure, recorded in Q4 2021.

• For the quarter ending Q4 2021, Non-Current Deferred Tax Liability fell 57.37% year-over-year to $183941.0; the trailing twelve-month figure through Dec 2021 stood at $183941.0 (down 57.37% YoY), and the FY2021 full-year result was $183941.0, down 57.37% from the prior year.
• Non-Current Deferred Tax Liability fell to $183941.0 in Q4 2021 per CTSO's latest filing, from $431490.0 in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $431490.0 in Q4 2020 and bottomed at $21856.0 in Q4 2018.
• Historically, Non-Current Deferred Tax Liability has averaged $257796.0 across 4 years, with a median of $288919.0 in 2019.
• The sharpest annual moves came in 2019 and 2021: Non-Current Deferred Tax Liability jumped 1702.24% in 2019, then plunged 57.37% in 2021.
• Over 4 years, Non-Current Deferred Tax Liability stood at $21856.0 in 2018, then surged by 1702.24% to $393897.0 in 2019, then climbed by 9.54% to $431490.0 in 2020, then slumped by 57.37% to $183941.0 in 2021.
• According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $183941.0, $431490.0, and $393897.0 for Q4 2021, Q4 2020, and Q4 2019 respectively.